Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22
Phase 41

Trial Status

Completed2
Other1

Role Distribution

Principal Investigator2
Other Roles1
PI Rate67%

Activity Timeline

Clinical Trials (3)

NCT04467983Phase 4Active Not Recruiting
Abaloparatide Added to Ongoing Denosumab vs Continued Denosumab Alone
Osteoporosis, Postmenopausal
StudydirectorStart date: 2021-02-01
NCT04249232Phase 2Completed
Abaloparatide and Pelvic Fracture Healing
Fracture of Pelvis (Disorder)
PrincipalinvestigatorStart date: 2020-09-17
NCT02972424Phase 2Completed
PTH(1-34) and Pelvic Fracture Healing - a Randomized Controlled Trial
Osteoporotic Fractures
PrincipalinvestigatorStart date: 2017-05-01

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Hospital for Special Surgery, New York

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Susan L Greenspan, MD

University of Pittsburgh

Related
6 trials

Shared therapeutic areas:

Osteoporosis, PostmenopausalOsteoporotic Fractures
Similarity Score20%

Joseph Lane, MD

Hospital for Special Surgery, New York

Related
1 trials

Shared therapeutic areas:

Fracture of Pelvis (Disorder)

Worked with same sponsors:

Hospital for Special Surgery, New YorkIcahn School of Medicine at Mount Sinai+3 more
Collaborated on 1 trial
Similarity Score14%

Athanasios D Anastasilakis, MD, PhD

424 General Military Hospital, Thessaloniki, Greece

Related
1 trials

Shared therapeutic areas:

Osteoporosis, Postmenopausal
Similarity Score10%

Frederic Dutheil

University Hospital, Clermont-Ferrand

Related
7 trials

Shared therapeutic areas:

Osteoporotic Fractures
Similarity Score10%

Stergios A Polyzos, MD, PhD

School of Medicine, Aristotle University of Thessaloniki

Related
2 trials

Shared therapeutic areas:

Osteoporosis, Postmenopausal
Similarity Score10%

Dimitrios G Goulis, MD, PhD

School of Medicine, Aristotle University of Thessaloniki

Related
2 trials

Shared therapeutic areas:

Osteoporosis, Postmenopausal
Similarity Score10%

Weibo Xia, MD

Peking Union Medical College Hospital

Related
3 trials

Shared therapeutic areas:

Osteoporotic Fractures
Similarity Score10%

Marie-Eva Pickering

University Hospital, Clermont-Ferrand

Related
4 trials

Shared therapeutic areas:

Osteoporosis, Postmenopausal
Similarity Score10%

Huma Riaz, Phd*

Riphah International University

Related
19 trials

Shared therapeutic areas:

Osteoporosis, Postmenopausal
Similarity Score10%

Berdine R Martin, PhD

Purdue University

Related
4 trials

Shared therapeutic areas:

Osteoporosis, Postmenopausal
Similarity Score10%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT04467983Phase 4StudyDirector

Abaloparatide Added to Ongoing Denosumab vs Continued Denosumab Alone

Osteoporosis, Postmenopausal
Active Not Recruiting
NCT04249232Phase 2PrincipalInvestigator

Abaloparatide and Pelvic Fracture Healing

Fracture of Pelvis (Disorder)
Completed
NCT02972424Phase 2PrincipalInvestigator

PTH(1-34) and Pelvic Fracture Healing - a Randomized Controlled Trial

Osteoporotic Fractures
Completed

All 3 trials loaded